Abstracts Archive - Page 1692 of 2607 - ACR Meeting Abstracts

Abstract Number: 1392 • 2016 ACR/ARHP Annual Meeting
Familial Aggregation of Autoimmune Diseases in Childhood and Adulthood Systemic Lupus Erythematosus
Nailu A. Sinicato¹, Luciana de Oliveira², Aline Tamires Lapa², Lilian Tereza Costallat³, Roberto Marini Sr.⁴, Timothy B. Niewold⁵ and Simone Appenzeller⁶, ¹Pediatrics, State University of Campinas, Campinas, Brazil, ²Medicine, State University of Campinas, Campinas, Brazil, ³RUA EZEQUIEL MAGALHAES,26, Unicamp, Campinas, Brazil, ⁴Pediatric Rheumatology Unit, State University of Campinas, São Paulo, Brazil, ⁵Rheumatology and Immunology, Mayo Clinic, Rochester, MN, ⁶Pediatric Rheumatology Unit, State University of Campinas, Campinas, Brazil
Background/Purpose: Genetic factors play a role in SLE, evidenced by the high sibling risk ratio (λs=8–29) and higher concordance rates between monozygotic twins (>35%) compared…
Abstract Number: 1393 • 2016 ACR/ARHP Annual Meeting
Mycophenolic Acid Pharmacokinetics in Childhood-Onset Systemic Lupus Erythematosus Patients of Hispanic Ethnicity in a Single Center
Anna Carmela Sagcal-Gironella¹, Marietta De Guzman¹, Daping Zhang², Lorita Agu² and Diana Chow², ¹Pediatric Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, ²Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX
Background/Purpose: Mycophenolic acid (MPA) is the biologically active metabolite of mycophenolate mofetil (MMF), a widely used immunosuppressant in the treatment of childhood-onset systemic lupus erythematosus…
Abstract Number: 1394 • 2016 ACR/ARHP Annual Meeting
A Pilot Study of Consensus Treatment Plans for Induction Therapy in Childhood Proliferative Lupus Nephritis
Jennifer C. Cooper¹, B. Anne Eberhard², Marilynn Punaro³, Stacy P. Ardoin⁴, Hermine I. Brunner⁵, Joyce Hsu⁶, Linda Wagner-Weiner⁷, Kelly Rouster-Stevens⁸, Laura E. Schanberg⁹, Marisa Klein-Gitelman¹⁰, Emily von Scheven¹¹ and CARRA Registry Investigators, ¹Pediatrics, Divison of Rheumatology, University of California, San Francisco, San Francisco, CA, ²Cohen Children's Medical Center of New York, New Hyde Park, NY, ³Texas Scottish Rite Hospital for Children, Dallas, TX, ⁴Pediatric & Adult Rheumatology, Ohio State University, Columbus, OH, ⁵Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁶Pediatric Rheumatology, Stanford University, Palo Alto, CA, ⁷Pediatric Rheumatology, University of Chicago Hospitals, Chicago, IL, ⁸Pediatric Rheumatology, Emory University School of Medicine, Atlanta, GA, ⁹Pediatrics, Duke Medical Center, Durham, NC, ¹⁰Division of Rheumatology, Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago/Northwestern University Feinberg School of Medicine, Chicago, IL, ¹¹Division of Rheumatology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA
Background/Purpose: Childhood-onset systemic lupus erythematous (cSLE) patients are at higher risk for renal disease than those with adult-onset disease. Mycophenolate mofetil (MMF) and intravenous…
Abstract Number: 1395 • 2016 ACR/ARHP Annual Meeting
Regional Brain Gray Matter Volume Loss in Children and Adolescents with SLE
Andrea Knight¹, Michelle Vickery², Jimit Doshi³, Guray Erus⁴, Arastoo Vossough⁵ and Susan Furth⁶, ¹Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, ²PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA, ³Section of Biomedical Image Analysis, University of Pennsylvania, Philadelphia, PA, ⁴Section on Biomedical Image Analysis, University of Pennsylvania, Philadelphia, PA, ⁵Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, ⁶Division of Nephrology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
Background/Purpose: Neuropsychiatric SLE in children and adolescents presents diagnostic challenge due to limitations of conventional magnetic resonance imaging (MRI) to detect clinically relevant brain changes.…
Abstract Number: 1396 • 2016 ACR/ARHP Annual Meeting
Cognitive Function in Children with SLE Nephritis: A Cross-Sectional Comparison to Children with Other Glomerular Chronic Kidney Diseases
Andrea Knight^1,2,3, Matthew Matheson⁴, Susan Furth⁵, Brad Warady⁶, Stephen Hooper⁷ and Amy Kogon⁸, ¹Division of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, ²PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA, ³Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, ⁴Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, ⁵Division of Nephrology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, ⁶Division of Nephrology, Children's Mercy Hospital, Kansas City, MO, ⁷Department of Allied Health Sciences, University of North Carolina School of Medicine, Chapel Hill, NC, ⁸Division of Nephrology, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH
Background/Purpose: Children with lupus nephritis (LN) are at risk for cognitive impairment due to effects on the brain from systemic inflammation and from potential effects…
Abstract Number: 1397 • 2016 ACR/ARHP Annual Meeting
Correlation and Responsiveness of Cutaneous Lupus Disease Area and Severity Index (CLASI) and Skindex-29 with Cutaneous Childhood Lupus Erythematosus (cSLE)
Ashwaq Aleed, CCHMC, cincinnati, OH; Pediatric, Qassim University, Qassim, Saudi Arabia
Correlation and Responsiveness of Cutaneous Lupus Disease Area and Severity Index (CLASI) and Skindex-29 with Cutaneous Childhood Lupus Erythematosus (cSLE) *Ashwaq AlEÕed, **Nora Al Mutairi ,…
Abstract Number: 1398 • 2016 ACR/ARHP Annual Meeting
Practice-Based Differences Between Pediatric Rheumatologists and Dermatologists Caring for Children with Discoid Lupus
Lisa Arkin¹, Kaveh Ardalan², Heather Brandling-Bennett³, Yvonne Chiu⁴, Benjamin Chong⁵, Megan Curran⁶, Raegan Hunt⁷, Amy Paller⁸, Victoria P. Werth^9,10, Marisa Klein-Gitelman⁶, Emily von Scheven¹¹ and for the CARRA SLE workgroup, ¹Department of Dermatology and Pediatrics;, University of Wisconsin School of Medicine & Public Health/American Family Children’s Hospital, Madison, WI, ²Division of Rheumatology; Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago/Northwestern University Feinberg School of Medicine, Chicago, IL, ³Division of Dermatology; Department of Pediatrics, Seattle Children’s Hospital/University of Washington School of Medicine, Seattle, WA, ⁴Department of Dermatology and Pediatrics, Medical College of Wisconsin / Children's Hospital of Wisconsin, Milwaukee, WI, ⁵Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, ⁶Division of Rheumatology, Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago/Northwestern University Feinberg School of Medicine, Chicago, IL, ⁷Departments of Dermatology and Pediatrics, Baylor College of Medicine / Texas Children’s Hospital, Houston, TX, ⁸Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine/Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, ⁹Dermatology, University of Pennsylvania, Philadelphia, PA, ¹⁰Dermatology, Veterans Affairs Medical Center, Philadelphia, PA, ¹¹Division of Rheumatology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA
Background/Purpose: Discoid lupus erythematosus (DLE) is rare in children. There are no consensus guidelines for management or screening for evolution to systemic lupus erythematosus (SLE).…
Abstract Number: 1399 • 2016 ACR/ARHP Annual Meeting
Transitioning Lupus Patients from Pediatric to Adult Rheumatology
Joyce Hui-Yuen¹, Ashlea Cook², Lisa F. Imundo³, Amy Starr², Andrew Eichenfield⁴ and Anca D. Askanase⁵, ¹North Shore-Long Island Jewish Health System, Lake Success, NY, ²Pediatric Rheumatology, Columbia University Medical Center, New York, NY, ³Assoociate Professor of Pediatrics in Medicine - Rheumatology, Columbia University Medical Center, New York, NY, ⁴Morgan Stanley Children's Hospital of NY-Presbyterian, Columbia University, New York, NY, ⁵Department of Medicine, Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY
Background/Purpose: Pediatric rheumatologists have successfully improved the life expectancy and quality of life of children with systemic lupus (cSLE). cSLE has higher morbidity and mortality…
Abstract Number: 1400 • 2016 ACR/ARHP Annual Meeting
Preliminary Validation of the Turkish Simple Measure of Impact of Lupus Erythematosus in Youngsters (SMILEY) in a Single Center
Gozde Yucel¹, Sezgin Sahin², Amra Adrovic², Kenan Barut², Ela Tarakci³, Ahmet Arvas⁴, Nandini Moorthy⁵ and Ozgur Kasapcopur⁶, ¹Istanbul University, Cerrahpasa Medical School, Department of Pediatric Rheumatology, Istanbul, Turkey, ²Pediatric Rheumatology, Istanbul University, Cerrahpasa Medical School, Department of Pediatric Rheumatology, Istanbul, Turkey, ³Istanbul University, Faculty of Health Science, Division of Physiotherapy and Rehabilitation, Istanbul, Turkey, ⁴Istanbul University, Cerrahpasa Medical School, Department of Pediatrics, Istanbul, Turkey, ⁵Robert Wood Johnson Medcal School, Department of Pediatric Rheumatology, New Brunswick, NJ, ⁶Department of Pediatric Rheumatology, Istanbul University, Cerrahpasa Medical School, Department of Pediatric Rheumatology, Istanbul, Turkey
Background/Purpose: Juvenile systemic lupus erythematosus (SLE) is a chronic multisystemic disease with an episodic course which is prevalent in all cultures with wide-ranging effects on…
Abstract Number: 1401 • 2016 ACR/ARHP Annual Meeting
Ultrasonography of Major Salivary Glands in Juvenile SjöGren’s Syndrome − Preliminary Findings in a Multi-Center Study
Daniel S. Hammenfors¹, Valeria Valim², Vibke Lilleby³, Blanca Bica⁴, Sandra Gofinet Pasoto⁵, Clovis Silva⁶, Juan Carlos Nieto⁷, Scott Lieberman⁸, Akaluck Thatayatikom⁹, Roland Jonsson¹⁰, Johan G. Brun¹¹ and Malin V. Jonsson¹², ¹Department of Rheumatology, Haukeland University Hospital, Bergen, Norway, ²Rheumatology, Department of Medicine, Universidade Federal do Espírito Santo, Vitória, Brazil, Vitória, Brazil, ³Rheumatology, Oslo University Hospital, Oslo, Norway, ⁴Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil, ⁵Internal Medicine, Division of Rheumatology - Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ⁶Department of Pediatric Rheumatology, Federal University of São Paulo, São Paulo, Brazil, ⁷Hospital General Universitario Gregorio Marañón and Complutense University, Madrid, Spain, ⁸Pediatrics (Division of Rheumatology), University of Iowa Children's Hospital, Iowa City, IA, ⁹University of Florida, Gainesville, FL, ¹⁰Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, ¹¹Department of Clinical Science, University of Bergen, Norway, Bergen, Norway, ¹²Department of Clinical Dentistry, Section for Oral and Maxillofacial Radiology, University of Bergen, Bergen, Norway
Background/Purpose: Juvenile Sjögren’s syndrome (jSS) is a rare, poorly defined and possibly underdiagnosed condition. Mean age of diagnosis is approximately 10 years, with major salivary…
Abstract Number: 1402 • 2016 ACR/ARHP Annual Meeting
Meeting the Needs of Adolescents with Autoimmune Diseases, the Development of a Clinical Transition Pathway
Margot Walter¹, Johanna M.W. Hazes², Radboud JEM Dolhain³, Philomine A. van Pelt⁴, A. Dijk van⁵ and Sylvia S.M. Kamphuis⁶, ¹Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands, ²Department of Rheumatology, Erasmus University Medical Centre, Rotterdam, Netherlands, ³Rheumatology, University Medical Center Rotterdam, Rotterdam, Netherlands, ⁴Rheumatology, Erasmus MC, Rotterdam, Netherlands, ⁵Sophia Children's Hospital, Erasmusmc, Rotterdam, Netherlands, ⁶Pediatric Rheumatology, Sophia Children's Hospital – Erasmus University Medical Centre, Rotterdam, Netherlands
Background/Purpose: Evidence based recommendations for transitional programs are available. Despite this, half of Young People (YP) do not make a successful transfer and implementation of…
Abstract Number: 1403 • 2016 ACR/ARHP Annual Meeting
Systematic Appraisal of the American College of Rheumatology Clinical Practice Guidelines
Ali Duarte-Garcia¹, Milena Cavalcante², Senada Arabelovic³ and John B. Wong², ¹Medicine, Tufts Medical Center, Boston, MA, ²Tufts Medical Center, Boston, MA, ³Division of Rheumatology, Tufts Medical Center, Boston, MA
Background/Purpose: The ACR practice guidelines establish U.S. and international treatment recommendations. We sought to characterize the quality of the guidelines using the Appraisal of Guidelines…
Abstract Number: 1404 • 2016 ACR/ARHP Annual Meeting
Systematic Review and Appraisal of Quality Measures for Inflammatory Arthritis
Matthew Cooper¹ and Claire E H Barber², ¹University of Calgary, Calgary, AB, Canada, ²Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: Quality measures are metrics health professionals can monitor to improve care delivery and patient outcomes. To be measurable they must include a specified numerator,…
Abstract Number: 1405 • 2016 ACR/ARHP Annual Meeting
Quality Measures in High Priority Rheumatologic Diseases: A Systematic Literature Review and Analysis
Melissa Wells¹, Stephanie Giattino¹, Malithi Jayasundara¹, Lisa Criscione-Schrieber¹, Arif Kamal² and Eugene William St.Clair¹, ¹Rheumatology, Duke University Medical Center, Durham, NC, ²Oncology, Duke University Medical Center, Durham, NC
Background/Purpose: To identify published quality measures in rheumatoid arthritis (RA), osteoarthritis (OA), osteoporosis, spondyloarthropathy (SpA) and gout for the purpose of summarizing the existing measures…
Abstract Number: 1406 • 2016 ACR/ARHP Annual Meeting
Towards Harmonized Data Collection in Rheumatoid Arthritis (RA): The EULAR Task Force for Standardizing a Minimum Data Collection for RA Observational Research
Helga Radner¹, Elena Nikiphorou², Katerina Chatzidionysiou³, Laure Gossec⁴, Kimme L. Hyrich⁵, Codruta Zăbălan⁶, Yvonne JL van Eijk-Hustings⁷, Paula Williamson⁸, William G Dixon⁹, Johan Askling¹⁰ and The EULAR Task Force for standardising minimum data collection in Rheumatoid Arthritis observational research, ¹Rheumatology, Medical University of Vienna, Vienna, Austria, ²Whittington Hospital, London, United Kingdom, ³Department of Medicine, Unit of Rheumatology, Department of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, ⁴Paris 06 University and AP-HP, Hôpital Pitié Salpêtrière, Paris, France, ⁵Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, ⁶Romanian League against Rheumatism, BUCHAREST, Romania, ⁷Patient&Care, Maastricht University Medical Centre, Maastricht, Netherlands, ⁸Clinical Trials Research Centre, University of Liverpool, Liverpool, United Kingdom, ⁹Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, Great Britain, ¹⁰Dept. of Medicine, Rheumatology Unit & Clinical Epidemiology Unit, Karolinska Institute, Stockholm, Sweden
Background/Purpose: Collaborative research is compromised by heterogeneity of data collection in observational rheumatoid arthritis (RA) databases. Therefore a EULAR taskforce has been convened to develop…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].